Home › Attention Deficit Hyperactivity Disorder › New York
Attention Deficit Hyperactivity Disorder clinical trials in New York
7 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in New York.
Cities in New York
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- The Medical Research Network, LLC, New York
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 14, 2026 · NCT07759154Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Staten Island
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Staten Island
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
- NYU Langone Health, New York
RecruitingPhase 4
Ages 18 to 60 · All sexes · Updated Apr 29, 2026 · NCT06577779AWARE: Management of ADHD in Autism Spectrum Disorder
- University of Rochester, Rochester
RecruitingPhase 4
Ages 4 to 17 · All sexes · Updated Oct 29, 2025 · NCT05916339A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
- Icahn School of Medicine at Mount Sinai, New York
RecruitingHealthy volunteers welcome
Ages 6 to 17 · All sexes · Updated Dec 11, 2024 · NCT06728969From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.